Takakura H, Kurosawa H, Mizuno A, Tatara A, Sakamoto Y, Saitoh F
Department of Cardiovascular Surgery, Jikei University School of Medicine, Tokyo.
Rinsho Kyobu Geka. 1994 Jun;14(3):221-3.
Making autologous fibrin glue from intraoperatively collected concentrated platelet rich plasma (C-PRP) was attempted in 5 patients who underwent elective coronary artery bypass. The autologous blood was withdrawn from the patient before cardiopulmonary bypass and sequestrated for C-PRP, concentrated red cells (CRC) and platelet poor plasma (PPP) using an Electromedics Elmd-500 autotransfusion device. CRC and PPP were returned intravenously to the patient as needed intraoperatively or postoperatively. Aprotinin was dissolved in C-PRP to yield a concentration of 1000U/ml to the aim of suppressing the plasmin activity. In another syringe, thrombin was dissolved in 2% calcium chloride solution to 1000U/ml. The C-PRP/aprotinin was mixed in ratios of 20:1, 10:1, 5:1, 3:1 to the thrombin/C a++ solution and observed the time for clotting. The 10:1 and 5:1 mixture usually clotted within 3-5 seconds, whereas it was necessary 5 or more seconds in other ratios. Therefore we used in the ratio of 5:1 for all patients. The fibrin glue from this technique is little different from the fibrin glue on the market in its viscosity, and has some major advantages 1. large amount of glue is available 2. simple and inexpensive 3. eliminate the risk of side effect such as virus transmission.
对5例行择期冠状动脉搭桥术的患者尝试用术中采集的浓缩富血小板血浆(C-PRP)制备自体纤维蛋白胶。在体外循环前从患者体内抽取自体血,使用Electromedics Elmd-500自动输血装置分离出C-PRP、浓缩红细胞(CRC)和少血小板血浆(PPP)。术中或术后根据需要将CRC和PPP静脉回输给患者。将抑肽酶溶解于C-PRP中,使其浓度达到1000U/ml,以抑制纤溶酶活性。在另一个注射器中,将凝血酶溶解于2%氯化钙溶液中,使其浓度达到1000U/ml。将C-PRP/抑肽酶与凝血酶/Ca++溶液按20:1、10:1、5:1、3:1的比例混合,观察凝血时间。10:1和5:1的混合物通常在3-5秒内凝固,而其他比例则需要5秒或更长时间。因此,我们对所有患者均采用5:1的比例。用该技术制备的纤维蛋白胶在粘度上与市售纤维蛋白胶几乎没有差异,并且具有一些主要优点:1. 可获得大量胶水;2. 简单且成本低廉;3. 消除了病毒传播等副作用风险。